Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 4.460
+0.620 (16.15%)
Apr 10, 2026, 5:07 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 92.1 million as of April 10, 2026. Its market cap has decreased by -86.31% in one year.
Market Cap
92.10M
Enterprise Value
424.69M
Revenue
287.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.46
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 92.10M, a decrease of -55.10%. That is a compound annual growth rate of -12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 79.29M | -78.18% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 126.56M |
| Simris Group AB (PUBL) | 115.81M |
| Biovica International AB | 105.09M |
| Scandinavian ChemoTech AB | 102.07M |
| Alligator Bioscience AB | 98.61M |
| Alzinova AB | 94.99M |
| Annexin Pharmaceuticals AB | 93.89M |
| OncoZenge AB | 82.60M |